– UK, London – Spire Healthcare Group plc (LSE: SPI), one of the UK’s leading independent hospital groups, is pleased to announce that it has appointed Justin Ash as its new Chief Executive Officer. Justin will take up his duties on 30 October 2017.

Justin was until recently the CEO of Oasis Healthcare Ltd, a post which he held for nine years, prior to which he was Managing Director of Lloyds Pharmacy. During his tenure at Oasis Healthcare, the company grew to become the leading independent provider of dental care in the UK, focusing on private care. Justin’s earlier career included ten years in senior roles with global consumer businesses.

Simon Gordon will continue as Interim CEO until 30 October, after which he will revert to the Chief Financial Officer role. The Board strongly believes that the combination of Justin and Simon will give Spire a first-rate senior management team to lead the Group’s further development.

Garry Watts, Chairman, said: “On behalf of the Board I would like to welcome Justin to Spire; he has a skillset particularly suited to developing Spire as the premier UK private hospital group and to creating and delivering a strategy focused on our private patients, whilst continuing to support the NHS.”

Justin Ash said: “Growing UK healthcare demand, coupled with patients’ desire for more choice, will continue to drive rapid growth in private provision, and Spire’s outstanding hospital estate, teams and service offering are ideally placed to satisfy and develop that demand. I am looking forward very much to joining Spire at this important stage in the Company’s life, and to meeting the leadership teams, staff and clinicians across the business.”


Spire Healthcare is a leading independent hospital group in the United Kingdom, with 39 private hospitals, 10 clinics and two Specialist Cancer Care Centres across England, Wales and Scotland.

Spire delivered tailored, personalised care to approximately 139,000 in-patients and daycase patients in the six months ended 30 June 2017, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. Spire is uniquely positioned to capture a growing share of the rapidly expanding private healthcare market. The Group’s well positioned and scalable hospitals have earned reputations as centres of excellence, delivering successful and award winning clinical outcomes, positioning the Group well with patients, consultants, the NHS, GPs and Private Medical Insurance (“PMI”) providers. Spire treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with longer life expectancy.

For more information : http://www.spirehealthcare.com

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Related Posts

Comments are closed.